CASP8 p.Arg435Gln
c.1304G>A · rs746401108 · VCV2155033
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0885 | likely benign |
|---|---|---|
| REVEL | 0.022 | moderately benign-leaning |
| SaProt | LLR -6.07 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | Δ0.42 | donor loss · deltas |
| Constraint at this position | ||
| Conservation | phyloP 1.2 | GERP -0.89, phastCons 0.99 |
| Regional constraint | o/e 0.82 | unconstrained · MANE · 20 kb · p 2.8e-05 · regional, not allelic |
| Overall | ||
| CADD | 20.5 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00626% | 15,983 |
| East Asiangrpmax | 0.00223% | 44,898 |
| South Asian | 0.0011% | 91,032 |
| European (non-Finnish) | 0.000678% | 147,502 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CASP8
- Protein
- p.Arg435Gln
- Coding
- c.1304G>A
- MANE Select
- NM_001372051
- dbSNP
- rs746401108
- Type
- single nucleotide variant
- Location
- chr2:201285317 (GRCh38)
- Gene constraint
- LOEUF 0.695 · pLI 0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 82.37 · 36 PDB
- Residue 435
- an α-helix
Disease context
autoimmune lymphoproliferative syndrome type 2B — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autoimmune lymphoproliferative syndrome-recurrent viral infections due to CASP8 deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- CASP8 p.Arg435Ter Pathogenic same residue
- CASP8 p.Arg248Trp Pathogenic/Likely pathogenic ★★ same condition
- CASP8 c.306-1926A>G Uncertain significance ★★ same condition
- CASP8 c.306-1935G>A Uncertain significance ★★ same condition
- CASP8 c.306-1971A>G Uncertain significance ★★ same condition
- CASP8 c.660+6C>T Uncertain significance ★★ same condition
- CASP8 c.*107C>T Uncertain significance ★★ same condition
- CASP8 p.Ala96Ser Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/casp8-p-arg435gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown